Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Acta Naturae|October 22, 2025
The Design, Synthesis, and Evaluation of the Biological Activity of Hydroxamic Derivatives of SorafenibA A Kleymenova, I A Abramov, Ya V Tkachev, et al.
Doklady. Biochemistry and Biophysics|February 14, 2023
Synthesis of 1-[ω-(Bromophenoxy)alkyl]-3-Naphthalenylmethyl Uracil Derivatives and Their Analogues as Probable Inhibitors of Human Cytomegalovirus ReplicationM P Paramonova, E S Gureeva, A A Ozerov, et al.
Doklady. Biochemistry and Biophysics|June 20, 2023
Synthesis of 1-[ω-(Bromophenoxy)alkyl]-3-naphthalenylmethyl Derivatives of Uracil and Their Analogues As Probable Inhibitors of Human Cytomegalovirus ReplicationM P Paramonova, E S Gureeva, A A Ozerov, et al.
FEBS Letters|January 29, 1999
Mapping of T7 RNA polymerase active site with novel reagents--oligonucleotides with reactive dialdehyde groupsV L Tunitskaya, E E Rusakova, L V Memelova, et al.
Intervirology|March 17, 2001
DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challengeM G Isaguliants, N N Petrakova, B Zuber, et al.
Molekuliarnaia Biologiia|September 1, 1991
[Reverse transcriptase of the human immunodeficiency virus: cloning, expression in Escherichia coli, purification of the enzyme, and production of monoclonal antibodies]V O Rechinskiĭ, S F Barbashov, I L Degtiarev, et al.
Molekuliarnaia Biologiia|October 2, 2024
[Cytotoxicity Studies of 5-Arylaminouracil Derivatives]V A Kezin, E S Matyugina, S A Surzhikov, et al.
Bioorganic & Medicinal Chemistry|January 9, 1999
Interaction of tRNA-derivatives and oligonucleotide primers with AZT-resistant mutants of HIV-1 reverse transcriptaseO D Zakharova, O A Suturina, O A Timofeeva, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 21, 2003
Oligonucleotides containing disaccharide nucleosides: synthesis, physicochemical, and substrate propertiesS N Mikhailov, E V Efimtseva, B S Ermolinsky, et al.
Acta Naturae|November 18, 2024
5'-Noraristeromycin Repurposing: Well-known S-Adenosyl-L-homocysteine Hydrolase Inhibitor As a Potential Drug Against LeukemiaO N Novikova, E S Matyugina, A V Gorshenin, et al.
Pageof 12